Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
ViroMissile, Inc.
Essen Biotech
Genentech, Inc.
USWM, LLC (dba US WorldMeds)
Daiichi Sankyo
Second Life Therapeutics
Novartis
Mayo Clinic
University Health Network, Toronto
NeoTX Therapeutics Ltd.
University of Pittsburgh
Tempus AI
Actym Therapeutics, Inc.
Pfizer
Arcus Biosciences, Inc.
Washington University School of Medicine
Cancer Research UK
NuCana plc
University of Virginia
Medicenna Therapeutics, Inc.
Marengo Therapeutics, Inc.
Eli Lilly and Company
NGM Biopharmaceuticals, Inc
Columbia University
Revolution Medicines, Inc.
Stanford University
Stanford University
Aminex Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
European Organisation for Research and Treatment of Cancer - EORTC
ADC Therapeutics S.A.
Pliant Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Celldex Therapeutics
Adaptimmune
University of Florida
Massachusetts General Hospital
Fate Therapeutics
Kineta Inc.
Prelude Therapeutics
Quadriga Biosciences, Inc.
Ludwig Institute for Cancer Research
Incyte Corporation
Revolution Medicines, Inc.
Incyte Corporation
Incyte Corporation
Hospices Civils de Lyon
Mie University